Luckham K, Tebbs H, Dadswell C, Yosef A, et al. Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometres. Eye (Lond) 2025 Sep 19. doi: 10.1038/s41433-025-04015.
PMID: 40973776